<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">CLOTRIMAZOLE</span><br/>(kloe-trim'a-zole)<br/><span class="topboxtradename">Canesten <img border="0" src="../images/maple.gif"/>, </span><span class="topboxtradename">Gyne-Lotrimin, </span><span class="topboxtradename">Gyne-Lotrimin-3, </span><span class="topboxtradename"> Lotrimin, </span><span class="topboxtradename">Mycelex, </span><span class="topboxtradename">Mycelex-G<br/></span><b>Classifications:</b> <span class="classification">antiinfective</span>; <span class="classification">antibiotic</span>; <span class="classification">antifungal</span><br/><b>Prototype: </b>Fluconazole<br/><b>Pregnancy Category: </b> B (topical); C (oral)<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>1% cream, solution, lotion; 10 mg troches; 100 mg, 200 mg, 500 mg vaginal tablets; 1% vaginal cream</p>
<h1><a name="action">Actions</a></h1>
<p>Has broad-spectrum fungicidal activity. Acts by altering fungal cell membrane permeability, permitting loss of phosphorous
         compounds, potassium, and other essential intracellular constituents with consequent loss of ability to replicate.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Active against <i>Trichophyton rubrum, Trichophyton mentagrophytes, Epidermophyton floccosum, Microsporum canis, Malassezia furfur,</i> and <i>Candida</i> sp, including <i>Candida albicans</i>. Natural or acquired fungal resistance to clotrimazole is rare.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Dermal infections including tinea pedis, tinea cruris, tinea corporis, tinea versicolor; also vulvovaginal and oropharyngeal
         candidiasis.
      </p>
<h1><a name="unlabeleduses">Unlabeled Uses</a></h1>
<p>Trichomoniasis.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Ophthalmic uses; systemic mycoses. Safe use during pregnancy (category C for oral troches, category B for topical preparations),
         lactation, and in children 
      </p><h1><a name="precaution">Cautious Use</a></h1>
<p>Hepatic impairment.</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Dermal Infections</span><br/><span class="rdage">Adult:</span> <span class="rdroute">Topical</span> Apply small amount onto affected areas b.i.d. a.m. and p.m.<br/><br/><span class="indicationtitle">Vulvovaginal Infections</span><br/><span class="rdage">Adult:</span> <span class="rdroute">Intravaginal</span> Insert 1 applicator full or one 100 mg vaginal tablet into vagina at bedtime for 7 d, or one 500 mg vaginal tablet at bedtime
               for 1 dose<br/><br/><span class="indicationtitle">Oropharyngeal Candidiasis</span><br/><span class="rdage">Adult/</span><span class="rdage">Child:</span> <span class="rdroute">PO</span> 1 troche (lozenge) 5 times/d q3h for 14 d<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1>
<ul>
<li>Instruct patient taking the oral lozenge to allow it to dissolve slowly in mouth over 1530 min for maximum effectiveness.
            
         </li>
<li>Apply skin cream and solution preparations sparingly. Protect hands with latex gloves when applying medication.</li>
<li>Avoid contact of clotrimazole preparations with the eyes.</li>
<li>Do not use occlusive dressings unless directed by physician to do so.</li>
<li>Consult physician about skin cleansing procedure before applying medication. Regardless of procedure used, dry skin thoroughly.</li>
<li>Store cream and solution formulations at 15°30° C (59°86° F); do not store troches or vaginal
            tablets above 35° C (95° F) unless otherwise directed.
         </li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">GI:</span> Abnormal liver function tests; occasional nausea and vomiting (with oral troche). <span class="typehead">Skin:</span> Stinging, erythema, edema, vesication, desquamation, pruritus, urticaria, skin fissures. <span class="typehead">Urogenital:</span> Mild burning sensation, lower abdominal cramps, bloating, cystitis, urethritis, mild urinary frequency, vulval erythema and
      itching, pain and vaginal soreness during intercourse. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span> Intravaginal preparations may inactivate <span class="classification">spermicides</span>. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Minimal systemic absorption; minimally absorbed topically. <span class="typehead">Peak:</span> High saliva concentrations Metabolism: Metabolized in liver. <span class="typehead">Elimination:</span> Eliminated as metabolite in bile. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Evaluate effectiveness of treatment. Report any signs of skin irritation with dermal preparations.</li>
<li>Anticipate signs of clinical improvement within the first week of drug use.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Use clotrimazole as directed and for the length of time prescribed by physician.</li>
<li>Generally, clinical improvement is apparent during first week of therapy. Report to physician if condition worsens or if signs
            of irritation or sensitivity develop, or if no improvement is noted after 4 wk of therapy.
         </li>
<li>If receiving the drug vaginally, your sexual partner may experience burning and irritation of penis or urethritis; refrain
            from sexual intercourse during therapy or have sexual partner wear a condom.
         </li>
<li>Do not breast feed while taking this drug.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>